Veronica Gagliardi | microcirculation | Best Researcher Award

Dr. Veronica Gagliardi | microcirculation | Best Researcher Award

Dr. Veronica Gagliardi, Università degli studi di Padova, Italy

Dr. Veronica Gagliardi is an Italian Medical Doctor specializing in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy. Born on August 22, 1996, in Spinea (VE), she is currently undergoing advanced clinical training at the University of Padua, where she has also undertaken a Level II Master in multimodal cardiac imaging. She combines academic excellence with frontline clinical experience in major regional hospitals, including Ospedale dell’Angelo in Mestre and Policlinico Universitario di Padova. Her work focuses on intensive care medicine, advanced echocardiography, and non-invasive ventilation strategies. Dr. Gagliardi is widely published, with a strong record in critical care, pain therapy, and ultrasound techniques. Her proactive involvement in clinical research and innovative therapies, including ECMO and auricular acupuncture, reflects a strong commitment to scientific advancement in patient care. She is a promising researcher and clinician, striving to integrate cutting-edge evidence with compassionate care.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Extensive Research Portfolio:
    Dr. Gagliardi has authored and co-authored over 10 peer-reviewed publications across respected international journals (Life, Medicina, Critical Care, Cureus, EJTM, Arch Clin Biomed Res), covering high-impact areas like ECMO, microcirculation, pain therapy, and non-invasive ventilation.

  2. Clinical-Research Integration:
    Her ability to bridge clinical practice and research is a standout quality. From ECMO and PEEP titration in COVID-19 to auricular electroacupuncture and ultrasound-guided pain procedures, she applies science directly to bedside care.

  3. Strong Academic Record:
    With a Medical Degree cum laude (110/110) and advanced training at the University of Padua, she demonstrates academic excellence, now furthered by a Level II Master in echocardiographic imaging.

  4. Leadership and Collaboration:
    She has actively participated in multi-center projects and international symposia, indicating both team leadership and scientific communication skills.

  5. Innovation and Versatility:
    Her research includes novel and multidisciplinary approaches—like capsaicin patch use for neuropathic pain and auricular diagnostics in oncology contexts.

⚙️ Areas for Improvement:

  1. Recognition and Awards:
    While her work is highly impactful, Dr. Gagliardi may benefit from more formal recognition, such as national/international fellowships, grants, or young investigator awards.

  2. Independent Research Funding:
    Securing her own research grants in the near future would further strengthen her research independence and global visibility.

  3. Broader Dissemination:
    Increasing her presence through conference presentations, keynote talks, or editorial roles would amplify the visibility of her work and boost her academic footprint.

🎓 Education:

Dr. Veronica Gagliardi earned her Master’s Degree in Medicine and Surgery with 110/110 with Honours from the University of Padua, completing an experimental thesis under Prof. Paolo Navalesi on respiratory failure in COVID-19 patients. Since November 2021, she has been enrolled in a five-year residency program in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy at the same institution, with rotations in several prominent hospitals. Starting November 2024, she will also undertake a Level II Master (ESTAV) in stress echocardiography, advanced transesophageal, and multimodal cardiac imaging, focusing on perioperative and interventional cardiac ultrasound techniques. Her education reflects not only clinical rigor but also a keen interest in research and innovation, particularly in areas like non-invasive ventilation, ultrasound diagnostics, and pain modulation. Her academic background is complemented by strong scientific output and peer-reviewed contributions in high-impact journals.

💼 Professional Experience:

Dr. Gagliardi has held the role of Medical Doctor specializing in Anaesthesiology and Intensive Care at Ospedale dell’Angelo in Mestre, starting in January 2025. Initially assigned to general anaesthesiology (UOS), she has since progressed to the Cardiac Intensive Care Unit (UOS) from May 2025. Her residency training from November 2021 to January 2025 included rotations in premier institutions such as Policlinico Universitario di Padova, Ospedale S. Antonio, Ospedale Ca’ Foncello, and Ospedale SS Giovanni e Paolo, gaining experience in critical care, pain therapy, perioperative medicine, and emergency interventions. Throughout her career, she has consistently demonstrated clinical versatility, excelling in high-pressure ICU settings. She combines clinical competence with advanced procedural skills, including echocardiography and ultrasound-guided regional blocks. This diverse clinical exposure underpins her contribution to complex case management and patient-centered care.

🏅 Awards and Honors:

Dr. Veronica Gagliardi has not been explicitly listed with specific awards, but her academic and research profile clearly reflects recognition-worthy achievements. She graduated with honors (110/110 cum laude) in Medicine, which stands as an early testament to her dedication and excellence. Her first-author publications in indexed journals, such as Life, Medicina, Critical Care, and EJTM, highlight her as a leading contributor to translational and clinical research in anesthesiology and critical care. Her participation in international symposiums, including the 40th International Symposium on Intensive Care & Emergency Medicine, and collaborations with established experts like Prof. Navalesi, further underscore her growing reputation. While formal honors such as Best Researcher Awards are yet to be listed, her CV is aligned with the standards of excellence and would merit such recognition in academic and clinical research circles.

🔬 Research Focus:

Dr. Gagliardi’s research is deeply rooted in critical care medicine, with a strong emphasis on microcirculation, non-invasive ventilation, pain management, and echocardiographic imaging. Her work spans experimental and clinical domains—from animal models exploring systemic morphine’s anti-inflammatory effects, to human studies on ECMO efficiency and caudal epidural injections. She has delved into innovative diagnostics like diaphragm ultrasound for predicting extubation outcomes, and non-conventional therapies such as auricular electro-acupuncture for microcirculatory modulation. Her research extends into the perioperative and post-operative use of non-invasive respiratory support, and stress echocardiography, bridging imaging and intensive care management. She actively collaborates on multi-center reviews and pilot studies, showing both independence and teamwork. Dr. Gagliardi’s research consistently aims at improving patient outcomes through evidence-based and minimally invasive approaches, contributing significantly to the evolving landscape of modern anaesthesia and critical care.

📚 Publications Top Notes:

📄 The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
📄 Recirculation in Veno-Venous Extracorporeal Membrane Oxygenation
📄 A Possible Correlation Between Auricular Angiomas and Breast Cancer Through Auricular Acupuncture Diagnosis: An Observational Case-Control Study
📄 Ultrasound-guided caudal epidural injection to treat symptoms of lumbar spinal stenosis: a retrospective study
📄 Effects of noninvasive respiratory support in post-operative patients: a systematic review and network meta-analysis
📄 Systemic Morphine but Not Local Administration Shows Preventive Anti-Inflammatory Effect in a Rat Model of Capsaicin-Induced Paw Edema
📄 Effect of Low- and High-Frequency Auricular Stimulation with Electro-Acupuncture on Cutaneous Microcirculation: A Cross-Over Study in Healthy Subjects
📄 Diaphragm Ultrasound: A Valuable Predictor of the Outcome of Extubation. An Observational Pilot Study in Covid-19 Related ARDS
📄 Persistent neuropathic pain treated with Capsaicin patches: a novel promising approach
📄 P101 Execution of percutaneous dilatational tracheostomy using the standard laryngeal mask airway for ventilation: a prospective survey study
📄 Positive end-expiratory pressure titration in COVID-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FiO2 tables

🧾 Conclusion:

Dr. Veronica Gagliardi is an exceptional emerging researcher who combines clinical acumen with a robust scientific mindset. Her research is innovative, clinically relevant, and methodologically sound, spanning critical areas like sepsis management, ECMO, echocardiography, and noninvasive ventilation strategies.

Zhi Guo | Stem Cell Research | Best Researcher Award

Prof. Dr Zhi Guo | Stem Cell Research | Best Researcher Award

Prof. Dr Zhi Guo | Department of Hematology, Huazhong University of Science and Technology Union Shenzhen Hospital | China

Dr. Zhi Guo is a distinguished expert in hematology with over 25 years of clinical and academic experience. Currently serving as Director, Academic Leader, Chief Physician, and Professor at the Department of Hematology, Huazhong University of Science and Technology Union Shenzhen Hospital, he has been instrumental in advancing hematologic malignancy treatments in China. With extensive expertise in hematopoietic stem cell transplantation, Dr. Guo has successfully performed more than 1,300 transplant cases. He began his career at the PLA Army General Hospital, serving there for nearly two decades before transitioning to his current role. A prolific researcher, he has authored over 10 peer-reviewed publications and five books, contributing substantially to the understanding of CAR-T therapy, gut microbiota, and transplantation immunology. He is an active member of major national and international hematology associations and plays a vital role in formulating clinical consensus and guidelines in China.

publication profile:

Scopus

Strengths for the Award:

Dr. Zhi Guo exemplifies the qualities of an outstanding medical researcher and clinician. With nearly 25 years of clinical experience in hematology and over 20 years in hematopoietic stem cell transplantation, he stands out as a national leader in this field. His performance of more than 1,300 transplants, along with a strong academic footprint, including 10 SCI-indexed publications in 2024–2025, demonstrates both depth and innovation in his research. He has also contributed to national expert consensus and clinical guidelines, particularly in CAR-T therapy and intestinal microecology. Dr. Guo’s leadership roles across national academic committees and his active membership in the American Society of Hematology further highlight his international impact and collaborative influence.

Areas for Improvement:

While Dr. Guo’s achievements in clinical practice and research are significant, opportunities exist to increase global visibility by expanding his research collaborations internationally and publishing in higher-impact journals beyond regional scopes. Additionally, while five books have been authored, the addition of patents or translational innovations could enhance his profile in the realm of research commercialization and practical medical technologies.

Education :

Dr. Zhi Guo holds a strong academic background in clinical medicine and medical research. He earned his Bachelor’s degree in Medicine from Tongji Medical College in 2000. Subsequently, he pursued his postgraduate medical studies at the Third Military Medical University, completing it in 2007. His academic journey culminated with the attainment of a Doctor of Medicine (MD) degree from Wuhan University of Science and Technology. His education laid a strong foundation in hematology and clinical research methodologies. Each step in his educational path was marked by an emphasis on academic rigor and clinical competence, preparing him for a leadership role in medical science and hematologic research. His multidisciplinary background has enabled him to integrate clinical insights with advanced laboratory-based innovations, contributing to national-level guidelines and the development of cutting-edge CAR-T cell therapies and transplantation techniques.

Experience :

Dr. Zhi Guo brings nearly 25 years of clinical, academic, and leadership experience in the field of hematology. He began his professional journey at the PLA Army General Hospital, where he served from 2000 to 2018. During this period, he honed his clinical and procedural expertise in managing complex hematologic disorders. Since 2018, he has been leading the Department of Hematology at Huazhong University of Science and Technology Union Shenzhen Hospital as Director, Academic Leader, and Chief Physician. His rich experience includes more than 1,300 hematopoietic stem cell transplantations, encompassing autologous, allogeneic, and CAR-T integrated therapies. His leadership extends beyond clinical care, as he also mentors postgraduate medical students and leads multiple national and institutional research projects. Dr. Guo’s practical experience is balanced with his strategic contributions to medical consensus formulation and research-driven policy initiatives in cancer and immune-hematological disorders.

Research Focus :

Dr. Zhi Guo’s research centers on hematologic malignancies and hematopoietic stem cell transplantation, particularly the integration of cellular immunotherapy such as CAR-T cell treatments. His recent work includes pioneering anti-CD19, anti-CD7, and anti-BCMA CAR-T therapies for lymphomas and leukemias. Additionally, he has investigated the interplay between microbiota and immune modulation in transplantation, highlighting the role of gut and oral microbiomes in patient outcomes. His contributions have influenced the development of clinical guidelines for microbiota-related diagnostics and treatments in oncology. With more than 10 high-impact journal publications and ongoing projects in translational medicine, Dr. Guo’s work combines laboratory innovation with patient-centered applications. He has also authored expert consensus documents and national guidelines, helping shape China’s hematology and transplantation protocols. His commitment to interdisciplinary collaboration, clinical innovation, and translational research underscores his leading role in advancing modern hematology.

Publications Top Notes:

  1. 🧬 In vitro validation of anti-CD19 CAR-T cells with LSD1 shRNA for DLBCLFront Immunol, 2025

  2. 🩸 Case of T-ALL treated with chemo + anti-CD7 CAR-T (retroviral vector)Front Immunol, 2025

  3. 👶 Shaping oral/intestinal microbiota & immunity in first 1,000 days of lifeFront Pediatr, 2025

  4. 💩 Fecal microbiota transplantation in acute GVHD treatmentJ Cancer Res Ther, 2024

  5. 🔬 Chinese consensus on gut microecology lab standardsExp Ther Med, 2024

  6. 🧪 2024 Chinese guidelines for intestinal microecology in cancerJ Cancer Res Ther, 2024

  7. 🧫 First MM case treated with ASCT + anti-BCMA CAR-T (retrovirus)Heliyon, 2024

  8. 🧾 Rapid response in relapsed FL to anti-CD19 CAR-T with CMVInt Immunopharmacol, 2024

  9. 🦷 Prognostic impact of oral microbiome in cancer survival – meta-analysisSyst Rev, 2024

  10. 🧍‍⚕️ Expert consensus on gut microbiome & hematopoietic stem cell transplantationClin Transplant, 2024

Conclusion:

In conclusion, Dr. Zhi Guo is highly suitable for the Best Researcher Award. His combination of clinical excellence, academic leadership, and impactful research in hematology and stem cell transplantation positions him among the top contributors in this specialized field. With ongoing research in CAR-T cell therapies, microbiota influence on transplantation, and immuno-oncology, Dr. Guo continues to shape the future of hematologic cancer care. Recognizing his contributions with this award would be both fitting and encouraging for continued innovation in this vital area of medicine.